Our technology is based on proprietary information using our ChondrostemTM.
ChondrostemTM is a marrow-based cell therapy allograft that regenerates, heals cartilage, and repairs damaged tissue. ChondrostemTM shuts down inflammation and degeneration and restores the natural matrix leading to full recovery and healing.
Our research shows outstanding results in joints and spinal repairs using minimally-invasive procedures to restore damaged discs and joint cartilage.
CCRT has developed intellectual property platforms based on cell therapy and pharmaceutical molecules. We have developed various therapies to target specific diseases with high rate of efficacy. Our therapies are at different stages of advanced clinical development, and some of them have already made it successfully to the market.